Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3194-3206

  Ledru, Eric ^a   Lecoeur, Hervé ^a   Garcia, Sylvie ^a   Debord, Thierry ^b   Gougeon, Marie Lise ^a  

^a INSTITUT PASTEUR   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 2; LAMIVUDINE; PROTEIN BCL 2; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD45; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-2; INTERPHASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642593019     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Sanders, M. E., M. W. Makgoba, and S. Shaw. 1988. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today 9:195.
2. Sanders, M. E., M. W. Makgoba, S. O. Sharrow, D. Stephany, A. Springer, H. A. Young, and S. Shaw. 1988. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J. Immunol. 140:1401.
3. + T cell clones. J. Immunol. 143:907.
4. Picker, L. J., M. K. Singh, Z. Zdraveski, J. R. Treer, S. L. Waldrop, P. R. Bergstresser, and V. C. Maino. 1995. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408.
5. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
6. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545.
7. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal cell death in T helper cell (Th1) and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 10:1837.
8. Varadhachary, A. S., S. N. Perdow, C. Hu, M. Ramanarayanan, and P. Salgame. 1997. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Nail. Acad. Sci. USA 94:5778.
9. Ameisen, J. C., and A. Capron. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102.
10. Gougeon, M., and L. Montagnier. 1993. Apoptosis in AIDS. Science 260:1269.
11. Finkel, T., G. Tudor-Williams, N. Banda, M. Cotton, T. Curiel, C. Monks, T. Baba, R. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat. Med. 1:129.
12. Gougeon, M. 1995. Does apoptosis contribute to CD4 T cell depletion in human immunodeficiency virus infection? Cell Death Differ. 2:1.
13. Roederer, M., J. G. Dubs, M. T. Anderson, P. A. Raju, and L. A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:2061.
14. Gougeon, M. L., H. Lecoeur, A. Dulioust, M. G. Enouf, M. Crouvoiser, C. Goujard, T. Debord, and L. Montagnier. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:3509.
15. Clerici, M., and G. M. Shearer. 1993. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107.
16. + T cell depletion occurs. J. Clin. Invest. 82:1908.
17. Clerici, M., F. Hakim, D. Venzon, S. Blatt, C. Hendrix, T. Wynn, and G. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
18. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 154:5031.
19. Barcellini, W., G. Rizzardi, M. Borghi, C. Fain, A. Lazzarin, and P. Merni. 1994. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 8:757.
20. Hyjek, E., H. Lischner, T. Hyslop, J. Bartkowiak, M. Kubin, G. Trinchieri, and D. Kozbor. 1995. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J. Immunol. 155:4060.
21. Meyaard, L., E. Hovenkamp, I. P. Keet, B. Hooibrink, I. H. de Jong, S. A. Otto, and F. Miedema. 1996. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals: decreased IFN-γ in the presence of preserved IL-4 production. J. Immunol. 157:2712.
22. Emilie, D., M. Peuchmaur, M. C. Crevon, N. Brousse, J. F. Delfraissy, J. Dormont, and P. Galanaud. 1990. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86:148.
23. Vyakarnam, A., P. Matear, A. Meager, G. Kelly, B. Stanley, I. Weller, and P. Beverley. 1991. Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals. Clin. Exp. Immunol. 84:109.
24. + lymphocytes of patients with AIDS synthesize increased amounts of interferon-γ. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:462.
25. Klein, S., J. Dobmeyer, T. Dobmeyer, M. Pape, O. Ottman, E. Helm, D. Hoelzer, and R. Rossol. 1997. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11:1111.
26. Graziosi, C., G. Pantaleo, and A. S. Fauci. 1994. Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. Res. Immunol. 145:602.
27. + T cells from patients with AIDS. Eur. J. Immunol. 17:1685.
28. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. De Carli, A. M. Pesce, G. Del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244.
29. + T-cell clones in human immunodeficiency virus infection. Blood 84:4262.
30. Gougeon, M. L., H. Lecoeur, F. Boudet, E. Ledru, S. Marzabal, S. Boullier, R. Roué, S. Nagata, and J. Heeney. 1997. The lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J. Immunol. 158:2964.
31. Schmid, I., C. H. Uittenbogaart, B. Keld, and J. V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170:145.
32. Lecoeur, H., E. Ledru, M. C. Prévost, and M. L. Gougeon. 1997. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209:111.
33. + T lymphocytes during HIV infection. J. Immunol. 156:2582.
34. Clerici, M., and G. M. Shearer. 1994. The Thl-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
35. + lymphocytes. Eur. J. Immunol. 25:644.
36. Brod, S., C. Rudd, M. Purvee, and D. Hafler. 1989. Lymphokine regulation of CD45R expression on human T cell clones. J. Exp. Med. 170:2147.
37. Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science 257:217.
38. Gougeon, M. L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. Aids Res. Hum. Retroviruses 9:553.
39. Boise, L. H., and C. B. Thompson. 1996. Hierarchical control of lymphocyte survival. Science 274:67.
40. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type-1 infection. J. Exp. Med. 180: 489.
41. + T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper IgE. J. Exp. Med. 181:423.
42. Graziosi, C., G. Pantaleo, K. R. Gnatt, J. P. Fortin, J. F. Demarest, O. J. Cohen, R. P. Sékaly, and A. Fauci. 1994. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248.
43. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759.
44. Diaz-Mitoma, F., A. Kumar, S. Karimi, M. Kryworuchko, M. Daftarian, W. Creery, L. Filion, and W. Cameron. 1995. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin. Exp. Immunol. 102:31.
45. Nasert, S., N. Burtchen, F. Kussebi, M. Millner, R. Kroczek, T. Jung, R. Schwinzer, U. Wahn, and H. Renz. 1996. Stimulation of IgE and IgA production by CD45RA T helper cells in atopic patients. J. Immunol. 157:441.
46. Folks, T., K. Clouse, J. Justement, A. Rabson, E. Duh, J. Kehrl, and A. Fauci. 1989. Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365.
47. Poli, G., and A. Fauci. 1993. Cytokine modulation of HIV expression. Semin. Immunol. 5:165.
48. Aukrust, P., N. Liabakk, F. Muller, E. Lien, T. Espevik, and S. Froland. 1994. Serum levels of tumor necrosis factor-alpha and soluble TNF receptors in human immunodeficiency virus type-1 infection: correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169:1186.
49. Than, S., R. Hu, N. Oyaizu, J. Romano, X. Wang, S. Sheikh, and S. Pahwa. 1997. Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. J. Infect. Dis. 175:47.
50. Ullum, H., J. Victor, T. Katzenstein, J. Gerstoft, P. Gotzsche, K. Bendtzen, P. Skinhoj, and B. Pedersen. 1997. Decreased short-term production of tumor necrosis factor-α and interleukin-1β in human immunodeficiency virus-seropositive subjects. J. Infect. Dis. 175:1507.
51. Wallis, R. S., M. Vjecha, M. Amir-Tahmasseb, A. Okwera, F. Byekwaso, S. Nyole, S. Kabengera, R. D. Mugerwa, and J. J. Ellner. 1993. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta2-microglobulin in HIV-1-associated tuberculosis. J. Infect. Dis. 167:43.
52. Hober, D., F. Ajana, M. Petit, C. Sartiaux, M. Boniface, M. Caillaux, Y. Mouton, P. Wattre, and M. Maniez-Montreuil. 1993. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37:785.
53. Wong, G., and D. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323:819.
54. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. Mak, B. Holzmann, and M. Kronke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587.
55. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331.
56. Akbar, A. N., and M. Salmon. 1997. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today 18:72.
57. Lerner, A., L. K. Clayton, E. Mizoguchi, Y. Ghendler, W. van Ewijk, S. Koyasu, A. K. Bhan, and E. L. Reinherz. 1996. Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J. 15:5876.
58. Groux, H., D. Monte, B. Plouvier, A. Capron, and J. C. Ameisen. 1993. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, Interferon-γ and accessory cells. Eur. J. Immunol. 23:1623.
59. Oyaizu, B. N., M. C. T. W., S. Than, and S. Pahwa. 1996. Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion. Blood 87:2361.
60. Liu, Y., and C. A. Janeway. 1990. Interferon γ plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 172:1735.
61. Novelli, F., M. M. D'Elios, P. Bernabei, L. Ozmen, L. Rigamonti, F. Almerigogna, G. Forni, and G. Del Prete. 1997. Expression and role in apoptosis of the α-and β-chains of the IFN-γ receptor on human Th1 and Th2 clones. J. Immunol. 159:206.
62. Russell, J. H., B. J. Rush, S. I. Abrams, and R. Wang. 1992. Sensitivity of T cells to anti-CD3-stimulated suicide is independent of functional phenotype. Eur. J. Immunol. 22:1655.
63. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, W. Wong, R. Kamen, D. Tracey, and H. Allen. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619.
64. Gamard, C. J., G. S. Dbaido, B. Liu, L. M. Obeid, and Y. A. Hannun. 1997. Selective involvement of ceramide in cytokine-induced apoptosis: ceramide inhibits phorbol ester activation of nuclear factor kB. J. Biol. Chem. 272:16474.
65. Susin, S. A., N. Zamzami, M. Castedo, E. Daugas, H. G. Wang, S. Geley, F. Fassy, J. C. Reed, and G. Kroemer. 1997. The central executioner of apoptosis. multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 1997:25.
66. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacharchuk. 1995. Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
67. Strasser, A., A. W. Harris, D. C. Huang, P. H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136.
68. van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
69. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995:3806.
70. Watanabe, N., H. Arase, K. Kurasawa, I. Iwamoto, N. Kayagaki, H. Yagita, K. Okumara, S. Miyatake, and T. Saito. 1997. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur. J. Immunol. 27:1858.
71. Nagata, S. 1997. Apoptosis by death factor. Cell 88.
72. Zheng, L., G. Fisher, R. Miller, J. Peschon, D. Lynch, and M. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348.
73. Speiser, D., E. Sebzda, T. Ohteki, M. Bachmann, K. Pfeffer, T. Mak, and P. Ohashi. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3055.
74. Sytwu, H., R. Liblau, and H. McDevitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
75. Lenardo, J. 1991. lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
76. Fournel, S., L. Genestier, E. Robinet, M. Flacher, and J. Revillard. 1996. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157:4309.
77. Akbar, A. N., N. Borthwick, M. Salmon, W. Gombert, M. Bofill, N. Shamsadeen, D. Pilling, S. Pett, J. E. Grundy, and G. Janossy. 1993. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: the role of apoptosis in T cell memory. J. Exp. Med. 178:427.
78. Akbar, A. N., N. J. Borthwick, R. G. Wickremasinghe, P. Panayoitidis, D. Pilling, M. Bofill, S. Krajewski, J. C. Reed, and M. Salmon. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26:294.
79. Adachi, Y., N. Oyaizu, S. Than, T. W. McCloskey, and S. Pahwa. 1996. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. J. Immunol. 157:4184.
80. + T cell homeostasis and function in advanced HIV disease. Science 277:112.
81. Kovacs, J. A., S. Vogel, J. M. Albert, J. Falloon, R. T. Davey, R. E. Walker, M. A. Polis, and K. S. Spooner. 1996. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. New Engl. J. Med. 335:1350.
82. Jacobson, E. L., F. Pilaro, and K. A. Smith. 1996. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA 93:10405.
83. Davey, R., D. Chaitt, S. Piscitelli, M. Wells, J. Kovacs, R. Walker, J. Falloon, M. Polis, J. A. Metcalf, H. Masur, G. Fyfe, and H. C. Lane. 1997. Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons. J. Infect. Dis. 175:781.
84. Centers for Diseases Control. 1992. 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. Morb. Mortal. Wkly. Rep. 41:1.